However, after the bevacizumab-sensitive and bevacizumab-resistant cells were separated from tumor-bearing mice, ESM1 expression in drug-resistant cells was still stable and highly expressed, with 2.1 times that of sensitive cells. This evidence concerns the gene ESM1 and neoplasm.